TALOTTA, FRANCESCO

TALOTTA, FRANCESCO  

Istituto di genetica e biofisica "Adriano Buzzati Traverso"- IGB - Sede Napoli  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autore(i) File
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer 1-gen-2023 Casalino L.; Talotta F.; Matino I.; Verde P.
The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting 1-gen-2022 Casalino, L; Talotta, F; Cimmino, A; Verde, P
Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein 1-gen-2010 Talotta F.; Mega T.; Bossis G.; Casalino L.; Basbous J.; JarielEncontre I.; Piechaczyk M.; Verde P.
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation 1-gen-2009 Talotta F.; Cimmino A.; Matarazzo M.R.; Casalino L.; De Vita G.; D'Esposito M.; Di Lauro R.; Verde P.
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts 1-gen-2007 Mazzieri, R; Furlan, F; D'Alessio, S; Zonari, E; Talotta, F; Verde, P; Blasi, F
Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription 1-gen-2007 Casalino, L; Bakiri, L; Talotta, F; Weitzman, Jb; Fusco, A; Yaniv, M; Verde, P
Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast 1-gen-2007 Furlan F.; Galbiati C.; Jorgensen N.R.; Jensen JE.; Mrak E.; Rubinacci A.; Talotta F.; Verde P.; Blasi F.